DuPont/Barr Enter Into Legal Truce With Five Product Promotion Accord
DuPont expects to begin marketing a Barr-developed oncology product in the first quarter of 2001 under an agreement reached by the two companies in their Coumadin dispute.
DuPont expects to begin marketing a Barr-developed oncology product in the first quarter of 2001 under an agreement reached by the two companies in their Coumadin dispute.